Applied Biotechnology Institute, Inc.

Funding and NIH signals

• NIH award NIH awarded $288K (SBIR Phase I 1R43DK148203-01, new, notice Sep 17, 2026); 2 NIH awards totaling $588K in the last 12 months. NIH RePORTER 1R43DK148203-01 (Sep 17, 2026)
  Evidence (2 events)

  • Sep 17, 2026 · NIH RePORTER 1R43DK148203-01
    Organization: APPLIED BIOTECHNOLOGY INSTITUTE; City/State: SAN LUIS OBISPO, CA; Project number: 1R43DK148203-01; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-09-17; FY total cost (award amount): 288221; Administering IC: National Institute of Diabetes and Digestive and Kidney Diseases; Project title: Production in maize of low-cost heat stable forms of GLP-1 and GIP receptor agonists for treatment of diabetes and obesity; Organization type: Domestic For-Profits
  • Aug 14, 2026 · NIH RePORTER 1R43AI186801-01A1
    Organization: APPLIED BIOTECHNOLOGY INSTITUTE; City/State: SAN LUIS OBISPO, CA; Project number: 1R43AI186801-01A1; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-08-14; FY total cost (award amount): 299936; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Production of low-cost heat stable forms of adalimumab in maize for treatment of inflammatory bowel disease.; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals